# A Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Sutured Dural Repair

> **NCT01174992** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ethicon, Inc.** · enrollment: 139 (actual)

## Conditions studied

- Dura Defects

## Interventions

- **BIOLOGICAL:** Evicel
- **OTHER:** Sutures only

## Key facts

- **NCT ID:** NCT01174992
- **Lead sponsor:** Ethicon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-09
- **Final completion:** 2011-10
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2012-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01174992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01174992, "A Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Sutured Dural Repair". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT01174992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*